- 223463-13-65-Bromo-2-iodopyridine
- 223463-14-7Boronicacid, B-(6-bromo-3-pyridinyl)-
- 22346-43-62-Naphthalenesulfonicacid, 4-hydroxy-7-(methylamino)-
- 22346-75-44-Pyridinemethanol,1-oxide
- 223480-78-22-Pyridinesulfonicacid, 3-methyl-
- 2234-82-4Magnesium,chloropropyl-
- 22348-31-8Pyrrolidine,2-(diphenylmethyl)-, (2R)-
- 22348-32-92-Pyrrolidinemethanol,a,a-diphenyl-, (2R)-
- 22348-38-5cis-4-Methylamino-cyclohexanol
- 22348-44-3TRANS-4-(METHYLAMINO)CYCLOHEXANOL
Hot Products
- 163521-20-82-Benzofurancarboxylic acid, 5-(1-piperazinyl)-, ethyl ester
- 180468-42-2Ethyl (S)-1-phenyl-1,2,3,4-tetrahydro-2-isoquinolinecarboxylate
- 86118-10-7D-Serine, O-methyl-,hydrochloride (1:1)
- 198481-32-2Bazedoxifene
- 156-60-5trans-1,2-Dichloroethylene
- 76778-22-8GBR 12935 dihydrochloride
- 1187-93-5Trifluoromethyl trifluorovinyl ether
- 114-70-5Benzeneacetic acid,sodium salt (1:1)
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Tofisopam |
EINECS | 244-922-3 |
| CAS No. | 22345-47-7 | Density | 1.155 g/cm3 |
| PSA | 61.64000 | LogP | 3.31270 |
| Solubility | DMSO: ~14 mg/mL | Melting Point |
155-159°C |
| Formula | C22H26N2O4 | Boiling Point | 478.973 °C at 760 mmHg |
| Molecular Weight | 382.459 | Flash Point | 195.179 °C |
| Transport Information | UN 3077 9/PG 3 | Appearance | white powder |
| Safety | 60-61 | Risk Codes | 22-50 |
| Molecular Structure |
|
Hazard Symbols |
 Xn, N
|
| Synonyms |
1-(3,4-Dimethoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3-benzodiazepine;7,8-Dimethoxy-1-(3,4-dimethoxyphenyl)-5-ethyl-4-methyl-5H-2,3-benzodiazepine;EGYT 341;Grandaxin;Seriel; |
Article Data | 15 |
Tofisopam Chemical Properties
Empirical Formula: C22H26N2O4
Molecular Weight: 382.4528
Melting Point: 155-159 °C
Index of Refraction: 1.558
Density: 1.15 g/cm3
Flash Point: 195.2 °C
Enthalpy of Vaporization: 71.48 kJ/mol
Boiling Point: 479 °C at 760 mmHg
Vapour Pressure: 7.13E-09 mmHg at 25 °C
Structure of Tofisopam (CAS NO.22345-47-7) :
XLogP3-AA: 3.2
H-Bond Donor: 0
H-Bond Acceptor: 6
IUPAC Name of Tofisopam (CAS NO.22345-47-7) : 1-(3,4-Dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine
Canonical SMILES: CCC1C(=NN=C(C2=CC(=C(C=C12)OC)OC)C3=CC(=C(C=C3)OC)OC)C
InChI: InChI=1S/C22H26N2O4/c1-7-15-13(2)23-24-22(14-8-9-18(25-3)19(10-14)26-4)17-12-21(28-6)20(27-5)11-16(15)17/h8-12,15H,7H2,1-6H3
InChIKey: RUJBDQSFYCKFAA-UHFFFAOYSA-N
Tofisopam Uses
Tofisopam (CAS NO.22345-47-7) is used as a drug which is a benzodiazepine derivative. It is indicated for the treatment of anxiety and alcohol withdrawal, and it is prescribed in a dosage of 50 – 300 mg per day divided into three doses. It possesses anxiolytic properties but it does not have anticonvulsant, skeletal muscle relaxant, sedative, motor skill-impairing or amnestic properties.
Tofisopam Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | 1950mg/kg (1950mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 12, Pg. 547, 1981. |
| mouse | LD50 | intravenous | 415mg/kg (415mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 12, Pg. 547, 1981. |
| mouse | LD50 | oral | 3800mg/kg (3800mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 12, Pg. 547, 1981. |
| mouse | LD50 | subcutaneous | > 10gm/kg (10000mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 12, Pg. 547, 1981. |
| rat | LD50 | intraperitoneal | 1270mg/kg (1270mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 12, Pg. 547, 1981. |
| rat | LD50 | intravenous | 103mg/kg (103mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 12, Pg. 547, 1981. |
| rat | LD50 | oral | 825mg/kg (825mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 12, Pg. 547, 1981. |
| rat | LD50 | subcutaneous | > 10gm/kg (10000mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 12, Pg. 547, 1981. |
Tofisopam Safety Profile
Hazard Codes: 
Xn
N
Risk Statements: 22-50
R22:Harmful if swallowed.
R50:Very toxic to aquatic organisms.
Safety Statements: 60-61
S60:This material and its container must be disposed of as hazardous waste.
S61:Avoid release to the environment. Refer to special instructions / safety data sheets.
RIDADR: UN 3077 9/PG 3
WGK Germany: 2
RTECS: DE9540000
HazardClass: 6.1(b)
PackingGroup: III
Tofisopam Specification
Tofisopam ,its cas register number is 22345-47-7. It also can be called Grandaxin ; Dextofisopam ; 7,8-Dimethoxy-1-(3,4-dimethoxyphenyl)-5-ethyl-4-methyl-5H-2,3-benzodiazepine and tofizopam . It is not reported as causing dependence to the same extent as other benzodiazepines, but is still recommended to be prescribed for a maximum of 12 weeks. Tofisopam (CAS NO.22345-47-7) is claimed to be a PDE10A inhibitor ,and so it may provide an alternative mechanism of action for its various therapeutic effects. This action is proposed to make tofisopam potentially useful as a treatment for schizophrenia.
What can I do for you?
Get Best Price
